Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

This study has been completed.

Study NCT00042094 Information provided by DynPort Vaccine Company LLC, A CSC Company

First Received: July 23, 2002 Last Updated: June 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2003
Estimated Primary Completion Date:	No date given